Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Chugai and Alebund Enter into Option and License Agreement for EOS789 under Development for Hyperphosphatemia

Saturday, July 10, 2021

Chugai Pharmaceutical Co Ltd and Alebund Pharmaceuticals Hong Kong Limited announced that they have entered into an option and license agreement regarding Chugais EOS an investigational agent under development for hyperphosphatemia EOS is an oral inh...

Merck and Inbrain Neuroelectronics Collaborate to Develop the Next Generation of Bioelectronic Therapies

Friday, July 09, 2021

Merck a leading science and technology company today announced a second collaboration agreement in its Bioelectronics innovation field with Innervia Bioelectronics a startup and subsidiary of Inbrain Neuroelectronics SL Barcelona Spain The aim of the...

Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined With a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML)

Friday, July 09, 2021

Vor Biopharma Nasdaq VOR or the Company a cell therapy company pioneering engineered hematopoietic stem cell eHSC therapies combined with targeted therapies for the treatment of cancer today announced the formation of a collaboration with Janssen Bio...

Toxicology IND Preclinical Research Services by Altogen Labs CRO

Tuesday, July 06, 2021

Altogen Labs a preclinical CRO provides essential safety and efficacy testing for novel medicines GLPcompliant pharmtox assays per FDA IND requirements Company works with renowned academic research organizations and pharmabiotech industry to reduce G...

Everest Medicines Announces that Spero Therapeutics Entered into Licensing Agreement with Pfizer Inc. for SPR206 in ex-U.S. and ex-Asia Territories

Monday, July 05, 2021

Everest Medicines a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products for patients in Greater China and other parts of Asia today announced that Spero Therapeutics Inc Nasdaq SPRO a licensing p...

Standigm Secures Strategic Investment from SK Chemicals for Expanding its AI-Drug Development Capacity

Saturday, July 03, 2021

Standigm Inc Standigm a leading workflow artificial intelligence AI drug discovery company and SK Chemicals Co Ltd SK Chemicals a life science and green chemicals company announced today that they have signed a strategic partnership contract for coll...

Mandos, LLC Completes Acquisition of Adrabetadex from Mallinckrodt Pharmaceuticals

Friday, July 02, 2021

Following approval from the United States Bankruptcy Court for the District of Delaware Mandos LLC Mandos today announced it has closed the acquisition of Adrabetadex also known as VTS a drug in development for the treatment of NiemannPick Type C dis...

Seres Therapeutics, Nestlé Health Science Announce SER-109 Co-Commercialization License Agreement

Friday, July 02, 2021

Seres Therapeutics Inc a leading microbiome therapeutics company announced today that it has entered into an agreement with Nestl Health Science to jointly commercialize SER Seres investigational oral microbiome therapeutic for recurrent Clostridioid...

Apellis and Beam Therapeutics Enter Exclusive Research Collaboration to Apply Base Editing to Discover Novel Therapies for Complement-Driven Diseases

Thursday, July 01, 2021

Apellis Pharmaceuticals Inc and Beam Therapeutics Inc announced an exclusive fiveyear research collaboration focused on the use of Beams proprietary base editing technology to discover new treatments for complementdriven diseases The companies will c...

Bioasis Technologies Inc. and Oxyrane UK Ltd. enter into a Research Collaboration

Thursday, July 01, 2021

Bioasis Technologies Inc and Oxyrane UK Ltd are pleased to announce the initiation of a research collaboration Bioasis is a preclinical researchstage biopharmaceutical company developing a proprietary xB platform technology for the delivery of therap...